Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

about

Introduction for the special issue on recent advances in drug delivery across tissue barriers.Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.

P2860

Q42691823-A86B47FB-8AE4-4551-9947-5812AEEA29E5 Q48159203-138F2EAE-0C43-4A4F-A89E-019ED09A469A

P2860

Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

Item

http://www.wikidata.org/entity/Q38881426

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tissue barriers and novel appr ...... injected insulin therapeutics.

@en

type

Item

label

Tissue barriers and novel appr ...... injected insulin therapeutics.

@en

prefLabel

Tissue barriers and novel appr ...... injected insulin therapeutics.

@en

P1476

Tissue barriers and novel appr ...... injected insulin therapeutics.

@en

P2093

Jennica L Zaro

http://www.w3.org/2001/XMLSchema#string

Juntang Shao

http://www.w3.org/2001/XMLSchema#string

Wei-Chiang Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review.

Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery.

Insulin degradation: progress and potential

Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding.

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp

Design of non-standard insulin analogs for the treatment of diabetes mellitus

Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process.

Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.

Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.

P304

e1156804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21688370.2016.1156804

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27358753

http://www.w3.org/2001/XMLSchema#string

P932

4910833

http://www.w3.org/2001/XMLSchema#string

Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

about

P2860

P2860

Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932